Skip to main content

Siokas Grigorios's Form 4/A amendment

Amended

Cosmos Health Inc. (COSM) · filed Jan 27, 2023

Accession no.
0001477932-23-000574
Filed
Jan 27, 2023
Trade date
Dec 19, 2022
Filing delay
39 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 21, 2022

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $3.00M. It was filed 39 days after the trade.

This amendment restates part of 0001477932-22-009480 (filed Dec 21, 2022). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Siokas GrigoriosCIK 0001660125Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 19, 2022Common Stock, $.001 par valuePPurchaseAcquired+260,870$11.50F2+$3,000,0051,130,774Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001477932-22-009480 (filed Dec 21, 2022).

Derivative securities (Table II)

Derivative transactions carried over from 0001477932-22-009480
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 19, 2022Common StockPPurchaseAcquired+260,870$11.50+$3,000,005260,870Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares were purchased by Mr. Siokas in a registered direct offering pursuant to the Company's "shelf" registration statement on Form S-3 (No. 333-267550) declared effective by the SEC on December 15, 2022.

F2

All share and per share amounts reflect a 1 for 25 reverse stock split effected on December 15, 2022 with the Secretary of State of Nevada.

Referenced by the price of 1 transaction in Table I.

Remarks

Remarks: This amendment is being filed pursuant to Amendment No. 1 to the Securities Purchase Agreement dated as of December 19, 2022 filed by the issuer on January 17, 2023. Under the amendment, Mr. Siokas delivered back to the issuer warrants to purchase 260,870 shares of common stock which were voided.

Read the full filing on SEC EDGAR (opens in a new tab)